• Hemisphere Energy will purchase up to 7,687,830 of its common shares for cancellation
  • The NCIB will commence on July 14, 2021 and will terminate on July 13, 2022
  • Purchases of common shares will be made on the open market through the facilities of the TSXV
  • Hemisphere Energy is a Canadian oil company
  • Hemisphere Energy Corporation (HME) opened trading at C$0.96 per share

The TSX Venture Exchange has accepted Hemisphere Energy’s (HME) Notice of Intention to renew its normal course issuer bid.

Hemisphere Energy will purchase up to 7,687,830 of its common shares for cancellation, representing approximately ten per cent of the current public float.

Purchases of common shares will be made on the open market through the facilities of the TSXV. Hemisphere will pay the prevailing market price for all purchased shares. 

Hemisphere believes that, from time to time, the market price of its common shares may not properly reflect the underlying, intrinsic value of the company, and that the purchase of common shares for cancellation will be beneficial to shareholders.

The NCIB will commence on July 14, 2021, and will terminate on July 13, 2022. The company has retained Canaccord Genuity Corp. as its broker to conduct the NCIB on its behalf.

Hemisphere Energy is a Canadian oil company focused on the sustainable growth of its conventional heavy oil assets.

Hemisphere Energy Corporation (HME) opened trading at C$0.96 per share.

More From The Market Online
The Market Online Video

Prospera Energy plots success with proven reserves, M&A plans

Prospera Energy (TSXV:PEI) CEO Samuel David discusses the company's latest news and the forecast for 2024 in an exclusive interview.

Parkland pays City of Burnaby $31K for emergency response

Parkland Corp. (TSX:PKI) cut a cheque to the City of Burnaby, B.C., to cover costs after an incident at its plant earlier this year.

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

Stockhouse Bullboards users have been tracking a trajectory among Bombardier, Baytex and Tilray that they hope will share comparable results.